Blood breakthrough opens pathway to malaria vaccine

MELBOURNE researchers have taken a major step ­towards the development of a vaccine to protect against the world’s most widespread ­malaria parasite.

They have solved the mystery of how the deadly parasite Plasmodium vivaxinfiltrates young human red blood cells, and have successfully stopped this process.

International researchers, led by the Walter and Eliza Hall Institute of Medical Research, first uncovered that the parasite latches on to a specific protein receptor on the surface of blood cell, called the transferrin receptor protein.

For the full article, please see visit

Hannah Pickford